Naslov
European Surveillance of Antimicrobial Consumption (ESAC): quality indicators of outpatient antibiotic use

Autori
Coenen, S ; Ferech, M ; Malhotra-Kumar, S ; Hendrickx, E ; Suetens, C ; Goossens, H

Kolaboracija
ESAC project group

Izvornik
European journal of public health (1101-1262) 16 (2006), S1; 79-80

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Outpatient ; antibiotic ; use

Sažetak
Background Indicators to measure health care quality are increasingly being developed and used both by health care professionals and policymakers. In the context of increasing antimicrobial resistance, we aimed to develop valid quality indicators for outpatient antibiotic use, producible on the basis of present ambulatory care (AC) data within ESAC. ESAC is an international network of surveillance systems, aiming to collect comparable and reliable data on antibiotic consumption in Europe, granted by DG/SANCO of the European Commission. Methods Thirty-four countries joined ESAC. In accordance with the ATC/DDD methodology (WHO, 2005) data on use of systemic antibiotics (J01) were collected for the period 1997–2004. For more information on the ESAC methodology, visit www.ua.ac.be/ESAC. In September 2005, 27 experts from 15 countries participating in a European Science Foundation workshop proposed a set of 24 indicators based on ESAC AC data, and subsequently scored their relevance to ‘reducing antimicrobial resistance’, ‘patient health benefit’, ‘cost-effectiveness’, and ‘public health policymaking’ using a 9 point Likert scale. The scores were processed according to the UCLA-RAND appropriateness method to assess the indicators’ validity. Results Twenty-two participants scored. Twelve indicators were rated as relevant to both ‘reducing antimicrobial resistance’ and ‘public health policymaking’ and can be considered as a valid set. For example, in 2004 the values for the indicator ‘total outpatient J01use in DDD per 1000 inhabitants per day (DID)’ ranged from 9.2 DID in Russia to 33.4 DID in Greece. The ratio of the consumption of broad to the consumption of narrow spectrum penicillins, cephalosporins, and macrolides {; ; ; ; J01[CR þ DC þ DD þ (F-FA01)]/J01(CE þ DB þ FA01)}; ; ; ; ranged from 0.1 in Sweden to 50.6 in Italy. The index of seasonal variation of quinolone consumption (J01M) taking into account their use in DID ranged from 0.00 in Greece and Hungary to 0.65 in Italy. Conclusions The subset of 12 valid quality indicators can be used to describe the quality of outpatient antibiotic use in Europe. The indicator values allow individual countries to position themselves and to define their own benchmark.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA